INVEGA: payments to doctors
Payments that named INVEGA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $589K
- Providers
- 6,661
- Transactions
- 17,240
- Average per transaction
- $34
The per-transaction average — $34 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 6,661 providers the average total is $88, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $507,318 | 86.2% |
| Janssen Scientific Affairs, LLC | $81,242 | 13.8% |